Year: 2025

The Company’s ThermoLoop uses inexpensive heat and water to potentially produce the world’s cheapest clean hydrogen  SANTA CLARITA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — NewHydrogen, Inc. (OTCMKTS: NEWH), the developer of ThermoLoop™, a breakthrough technology that uses water and heat instead of electricity to produce the world’s cheapest green hydrogen, announced today that it has jointly filed a second provisional patent application with the University of California, Santa Barbara (“UCSB”) for its innovative clean hydrogen production process. The patent, titled “Improved Materials and Methods For Production of Chemicals By Thermochemical Looping,” is a comprehensive provisional patent application that describes the most recent improvements to the Company’s ThermoLoop thermochemical water splitting process together with...

KELLOGG, Idaho and VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR; OTCQB: BHLL) announces that it has entered into an agreement with a former director of the Company (the “Recipient”) with respect to the settlement of an aggregate of 851,134 vested deferred share units of the Company (the “DSUs”) previously granted to the Recipient for services rendered as a director of the Company for the 2023 and 2024 fiscal years (the “Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, the Company has agreed to issue 615,384 shares of common stock of the Company (the “DSU Shares”) to the Recipient at a deemed issue price of C$0.195 per DSU Share, representing the closing price of the shares of common stock of the Company (“Common Shares”)...

New York, New York, Nov. 03, 2025 (GLOBE NEWSWIRE) — Westin Acquisition Corp, a blank check company incorporated in the Cayman Islands as an exempted company (the “Company”), today announced the pricing of its initial public offering (“IPO”) of 5,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right to receive one-sixth (1/6) of one Class A ordinary share upon the consummation of an initial business combination. The units are expected to trade on The Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “WSTNU” beginning November 4, 2025. The Company expects the IPO to close on November 5, 2025, subject to customary closing conditions. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the rights are expected...

JERICHO, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) — Kimco Realty Corp. (NYSE: KIM) (the “Company” or “Kimco”) today announced the establishment of an “at the market” continuous offering program, pursuant to which the Company may offer and sell shares of its common stock, par value $0.01 per share, with an aggregate gross sales price of up to $750,000,000 through BofA Securities, Inc., Barclays Capital Inc., BMO Capital Markets Corp., BNP Paribas Securities Corp., BNY Mellon Capital Markets, LLC, BTIG, LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Jefferies LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Nomura Securities International, Inc., RBC Capital Markets, LLC, Regions Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 03, 2025 (GLOBE NEWSWIRE) — Integral Metals Corp. (CSE: INTG | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that it has upsized its previously announced (please see news release dated October 17, 2025) non-brokered flow-through private placement of units (“FT Units”), from gross proceeds of up to C$1,000,000 to gross proceeds of up to C$1,500,000 (the “Offering”). Each FT Unit is priced at $0.95 per FT Unit and will be comprised of one flow-through common share of the Company (each, a “FT Share”) and one (non-flow-through) common share purchase warrant of the Company (each whole warrant, a “Warrant”), with each Warrant entitling the holder to acquire one common share (each, a “Warrant Share”)...

ROCKVILLE, Md. and SUZHOU, China, Nov. 03, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that the latest results from multiple clinical studies of its novel drug, olverembatinib (HQP1351), have been selected for presentations at the 67th American Society of Hematology (ASH) Annual Meeting, marking the eighth consecutive year in which clinical data on olverembatinib have been selected by ASH for the Annual Meeting. This year, multiple clinical and preclinical studies on three of the company’s investigational drug candidates (olverembatinib, lisaftoclax and APG-5918) have been...

ROCKVILLE, Md. and SUZHOU, China, Nov. 03, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that the latest results from two clinical studies of its novel drug, lisaftoclax (APG-2575), have been selected for presentations, including an oral report, at the 67th American Society of Hematology (ASH) Annual Meeting. This is the fourth consecutive year in which clinical results on lisaftoclax have been selected by the ASH Annual Meeting. This year, data from multiple clinical and preclinical studies on three of the company’s investigational drug candidates (lisaftoclax, olverembatinib,...

Reference is made to the stock exchange announcement made by Zelluna ASA (the “Company“) on 3 November 2025 regarding the allocation of 5,500,000 new shares in the Company in a private placement (the “Private Placement“), the allocation of 315,639 new shares in a retail offering via the PrimaryBid platform (the “PrimaryBid Offering“), and a potential subsequent repair offering of up to 800,000 new shares at the same subscription price as in the Private Placement and the PrimaryBid Offering (the “Subsequent Offering“). The Subsequent Offering will, subject to applicable securities law, be directed towards existing shareholders in the Company as of 3 November 2025, as registered in the Company’s register of shareholders with Euronext Securities Oslo on 5 November 2025, who (i) were not...

HOUSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of October 31, 2025. As of October 31, 2025, the Company’s net assets were $2.2 billion, and its net asset value per share was $13.13. As of October 31, 2025, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 663% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 486%.STATEMENT OF ASSETS AND LIABILITIESOCTOBER 31, 2025   // (UNAUDITED)     (in millions)Investments   $ 3,074.3  Cash...